β-Lactam ring-containing compounds play a pivotal role in drug design and synthetic chemistry. Spirocyclic βlactams, representing an important β-lactam subclass, have recently attracted considerable interest with respect to new synthetic methodologies and pharmacological applications. The aim of this manuscript is to review the recent progress made in this field, covering publications disseminated between 2011 to 2018 concerning the synthesis and application of spirocyclic β-lactams. In the first part, new approaches to the synthesis of spirocyclic β-lactams, including Staudinger synthesis, cyclization and transformation reactions, will be presented. The reactivity and biological properties of spiro-β-lactams will be described in the second and third part, respectively.
Introduction
The β-lactam (azetidin-2-one) ring is one of the most significant azaheterocycles studied from both a synthetic and medicinal chemistry point of view in the last decades. Its prominence is due to the presence of the β-lactam core in many antibiotics (e.g., penicillins, carbapenems, monobactams and sulbactams) used in the fight against pathogenic bacteria. In addition to their antibacterial properties, β-lactams possess other pharmacological activities such as cholesterol absorption inhibition, anti-inflammation, anti-tubercular and anti-HIV activity. 1 Over the years, β-lactams have also emerged as versatile building blocks (β-lactam synthon method) for the synthesis of amino acids, alkaloids and taxoids with potential biological properties. [2] [3] [4] [5] In the light of these excellent applications, much attention has been devoted to development of novel and more effective β-lactam compounds and the evaluation of their biological and synthetic potential. 1, 6 On the other hand, the overuse of β-lactam antibiotics leads to an increasing number of resistant bacterial strains. These new challenges have given impetus to the search for the replacement or modification of the available βlactam structures to meet current urgent needs. [7] [8] [9] Spirocyclic β-lactams, which contain a (small) ring spiro-fused at the C3 or C4 position of a β-lactam core (Figure 1) , have recently been found to be eligible candidates for drug discovery. They have, for example, been exploited as antibacterial agents, antiviral agents and cholesterol absorption inhibitors. In that respect, structure-activity relationship studies have identified 3-spiro-cyclohexyl-β-lactams SCH 54016 A and SCH 58053 B as two potential cholesterol absorption inhibitors. 10 In addition, spiro-β-lactams have been used as βturn mimetics in peptidomimetic chemistry. It has been found that spiro-β-lactams also act as poliovirus and human rhinovirus 3C-proteinases inhibitors. Thus, the search for new spiro-β-lactam derivatives comprises a relevant research topic. 10 In addition, spiro-β-lactams have been used as starting materials to prepare α-and β-amino acids, alkaloids, heterocycles, taxoids 11 and other relevant compounds. 12 In that respect, several new methodologies for the synthesis of spiro-β-lactams have been developed, as is evident from the many reviews in the field. [11] [12] [13] The spirocyclic indeno [1,2-b ]quinoxaline β-lactams 5 and 6 were prepared by treatment of N-phenyl-11Hindeno[1,2-b]quinoxalin-11-imine derivatives 4 with various phenoxyacetic acid derivatives in the presence of triethylamine and tosyl chloride in anhydrous CH 2 Cl 2 at room temperature (Scheme 2). The diastereomeric ratio of 5 and 6 (50:50) was determined by the integration of the proton H-3. The structures of β-lactams 5 and 6 were further confirmed by X-ray crystallography. 16
Scheme 2
The synthesis and pharmacological evaluation of isatin-derived compounds has attracted the attention of many research groups. 13, [17] [18] [19] [20] For example, in the course of a screening study for β-lactam compounds possessing antibacterial and antifungal activities, Shah and co-workers successfully synthesized a number of novel spiro[azetidine-2,3 ' -indole]-2 ' ,4(1 ' H)-diones 10 and 12 by means of the Staudinger synthesis (Scheme 3). The preparation of imines 9 and 11 was performed by reaction between either dibromoisatin 8, which was obtained by treatment of isatin 7 with bromine in methanol, or isatin 7 with different primary aromatic amines in absolute ethanol in the presence of glacial acetic acid. Subsequently, treatment of imines 9 and 11 with chloroacetyl chloride in the presence of a tertiary base at 80 °C to reflux temperature led to the target spiro-βlactams 10 and 12. The antibacterial and antifungal activities of these spiro β-lactams were evaluated. 21 In addition, the cyclocondensation of isatin-3-arylimine with various diazoketo esters catalyzed by rhodium(II) also gave rise to spiro(oxindolyl)-β-lactams. 22 Recently, the Kandile group has reported the generation of bis-spiroazetidinone derivatives by the reaction of bis-Schiff bases, derived from 5-substituted isatins, with chloroacetyl chloride. 23 Concurrently, Xu and co-workers have disclosed a direct asymmetric [2+2]-annulation reaction of simple aliphatic aldehydes with isatin-derived ketimines via N-heterocyclic carbene (NHC) catalysis furnishing enantioenriched spiroindole β-lactams. 24 The synthesis of spiro-fused seleno-β-lactams has been studied by using Z/E isomers of α-seleniumsubstituted exocyclic imines 13 with various types of acyl chlorides, such as methoxy-, chloro-, propionyl-, phenyl-, cyclohexyl-, phenoxy-, and p-chlorophenoxyacetyl chloride under optimized Staudinger synthesis conditions (Scheme 4). The reaction of exocyclic imines 13 with acetyl chlorides 14 gave rise to spiro-β-lactams 15 in excellent yields as mixtures of stereoisomers. The diastereomeric ratio (d.r.) of the resulting spiro-βlactams 15 was calculated by 1 H NMR spectral analysis. It should be noted that the stereochemical outcome of β-lactam formation under Staudinger reaction conditions can be explained by the electronic effects of the substituents on the ketenes, which were generated from the corresponding acid chlorides. 25
Scheme 4
The synthesis of new spiro-fused azetidinone-androgen derivative 19 began with the conversion of 17b-[(tert-butyldimethylsilyl)oxy]androst-4-en-3-one 16 to Schiff's base 17 using boric acid as a catalyst (Scheme 5). The treatment of compound 17 with dihydrotestosterone afforded thiourea 18. The later compound 18 was further converted into the desired bis-spiro steroidal β-lactam 19 by treatment with chloroacetyl chloride in the presence of triethylamine. The Staudinger-based synthesis of androgen derivative 19 constitutes a straightforward procedure in comparison with other methodologies applied in the synthesis of steroid derivatives. 26
Scheme 5
The reaction of imines 23 with chloroacetyl chloride in dimethylformamide yielded the corresponding spiro-fused β-lactam derivatives 24 (Scheme 6). The required imines 23 were prepared by condensation of bicycle 22 with nitroso derivatives in dimethylformamide in the presence of piperidine as a catalyst. In turn, bicycle 22 was synthesized from 4-acetyl-5-amino-3-methyl-1-phenyl-2-pyrazoline 21 by an intramolecular Mannich reaction. Pyrazoline 21 was derived from 4-acetyl-5-imino-3-methyl-1-phenyl-2-pyrazoline 20 by a reductive reaction using Zn/AcOH. 27 Anand and co-workers 28 have reported the facile synthesis of axial and equatorial spiro-β-lactams 26 via the entrapment of cyclohexanone imines 25 with acetoxyacetyl chloride in a [2+2]-cyclocondensation at -78°C (Scheme 7). The resulting conformations of 4-substituted 1-azaspiro[3.5]nonan-2-ones 26, which could be isolated as stable, pure crystals, were confirmed by X-ray crystallography. The restricted conformers were kinetically resolved using lipases. The mechanism of spiro-β-lactam 26 formation was explored using B3LYP/6-31+G* level quantum chemical calculations. 28
Scheme 6

Scheme 7
Imines 27, derived from 8-azabicyclo[3.2.1]octan-3-ones, have been shown to be interesting starting materials for the synthesis of a new class of β-lactams 28 via Staudinger synthesis with phenoxyacetyl chloride (Scheme 8). It is noteworthy that the stereochemical outcome of the obtained spiro-β-lactams (as single diastereoisomers) was opposite to the expected products of a [2+2]-cycloaddition reaction, which should have taken place from the exo face of compound 27. 29 The Reddy group 30 has reported on the synthesis and biological evaluation of a novel series of spiroazetidin-2-ones 33 starting from 3-chloro-4-fluoroaniline 29 (Scheme 9). Firstly, the benzothiazole 30 was synthesized from 3-chloro-4-fluoroaniline 29 and further condensed with 5-methyl-2-phenylpyrazol-3-one to yield the imine 31, which was cyclized with chloroacetyl choride in triethylamine to obtain azetidin-2-one 32. Finally, the resulting azetidin-2-one 32 was further condensed with different primary and secondary amines, leading to the desired spiro-fused β-lactams 33. These β-lactams 33 exhibited moderate to significant activities in anti-inflammatory, anti-diabetic, anti-oxidant and anti-microbial tests. 30
Scheme 8
Scheme 9
In an analogous approach, spiro-[chloroazetidinethiazolopyrimidine] derivatives were obtained by using the corresponding thiazolopyrimidine imines. 31 
Reactions of cyclic ketenes.
The utilization of cyclic ketenes in the [2+2]-cyclocondensation with imines constitutes an alternative approach for the preparation of spiro-β-lactams. 6, [32] [33] [34] [35] The generation of ketenes by the treatment of an acyl chloride with triethylamine is one of the most common methods; however, this approach has sometimes encountered disadvantages such as commercial unavailability, instability and difficulties related to the preparation of acid halides. 36 To deal with these difficulties, the Zarei and Sardarian groups have independently devoted efforts to the preparation of a cyclic ketene from the corresponding xanthene-9-carboxylic acid 34 using different carboxylic activators 36 to synthesize spiro-β-lactams 37 by Staudinger reaction with imines 35 (Scheme 10, Table 1 ). 15, [36] [37] [38] [39] [40] [41] [42] [43] The structure of 1-[3-(morpholin-4-yl)propyl]-4-(3-nitrophenyl)spiro[azetidine-3,9'-xanthen]-2-one -an analog of spiro-β-lactams 37 -was successfully determined for the first time by Akkurt via single-crystal X-ray analysis. 44 
Scheme 10
The substituted norbornane carboxylic acids 38 have been used for the formation of the corresponding bicyclic norbornane-derived ketenes by a two-step procedure. The cycloaddition of the so-formed ketenes with imine 39 led to the generation of diastereomeric norbornane C3-spiro-β-lactams 40, 41, 42, 43 (Scheme 11, Table 2 ). It is noteworthy that the stereochemical outcome of spiro-β-lactams 40-43 is influenced by the presence of encumbering groups on the cyclic ketenes. In fact, a better selectivity was obtained when methyl groups were present near to the carbon bearing the carboxylic functional group. The ratio of diastereoisomers was determined by integration of the H-4 proton in the 1 H-NMR spectra of the crude reaction mixtures. 45 To study the synthesis of spiro-β-lactam 46 on a larger scale, the reaction of in situ generated ketene from compound 44 and imine 45 was conducted in both batch and flow mode (Scheme 12). The reaction outcome showed that the Staudinger synthesis in a continuous flow process was deemed a safe method for this highly exothermic reaction. However, the precipitation of generated salts quickly blocked a glass chip and made the operation technically impossible. 46 
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Recently, the Mykhailiuk group 47, 48 has reported on a new approach for the synthesis of 3-substituted piperidinyl spiro-β-lactam 51 starting from acid 47 and aldehyde 49 (Scheme 13). In this synthetic approach, acid 47 was firstly converted into the corresponding acid chloride and subsequently into ketene 48 by the sequential treatment with SOCl 2 and NEt(iPr) 2 . Aldehyde 49 was converted into imine 50 upon treatment with LiN(TMS) 2 . In analogy, a diverse number of spiro-β-lactams attached with 4-, 5-, 6-, 7-membered rings at the C-3 position were prepared in moderate to good yields. Subsequently, the reductive removal of the carbonyl group of spiro-β-lactam analogs 51 was conducted by the reducing reagent AlH 3 giving the corresponding spirocyclic azetidines, which were investigated further in drug design and as an analog of the anesthetic drug bupivacaine. 47, 48 Scheme 13
Cyclization reactions
A convenient entry toward the construction of spirocylic β-lactams comprises the cyclization of β-amino acid derivatives and β-functionalized amides. 13 In that respect, Zhang and co-workers 49 have developed novel synthetic routes to produce several spiro-4-cyclohexadienonyl-β-lactams 53 from N-(4-hydroxyphenyl)-3oxopropanamides 52 through dearomatization and cyclization processes with iodobenzene diacetate (IBD) as oxidant in the presence of a stoichiometric amount of copper(II) sulfate pentahydrate and 4-dimethylaminopyridine (DMAP). 49 Later, this method was modified by using only a catalytic amount of copper(II) sulfate pentahydrate and 4-dimethylaminopyridine (DMAP), which gave similar yields (Scheme 14). 50
Scheme 14
In addition, this modification also allowed for the synthesis of a diverse number of spiro-4cyclohexadienone-β-lactams 55 with cyclopentanone, γ-lactone, and γ-lactam side chains on their C3 position, starting from the corresponding amides 54 (Scheme 15). 50
Scheme 15
Furthermore, the replacement of copper(II) sulfate pentahydrate by [Cu 3 ((S)-PIA) 2 (1,4dioxane)(H 2 O) 2 ]2(1,4-dioxane)H 2 O (L-1) has been shown to be equally effective in the preparation of spiro-4cyclohexadienonyl-β-lactam analogs. 51 In independent research, Xu has described the synthesis of 4-spiro-cyclohexadienonyl-β-lactam-3-carbonitriles 57 by means of the intramolecular nucleophilic cyclization of N-(p-hydroxyphenyl)cyanoacetamides 56 with iodobenzene diacetate (IBD) as oxidant and potassium hydroxide as base (Scheme 16). 10
Scheme 16
The cyclization of Dab-derived (Dab = 2,4-diaminobutanoic acid) chloroacetyl compound 59, which was obtained in a quantitative yield by treatment of compound 58 with chloroacetyl chloride in the presence of propylene oxide, gave rise to 1,6-diazaspiro[3.4]octane-2,5-dione 60 (Scheme 17). The construction of spirocylic β-lactam 60 could be explained by the concomitant formation of the β-lactam and pyrrolidinone ring, the latter due to a 5-exo-trig ring closure between the ZNH group and the carboxylic ester, followed by Zprotecting group removal. 52
Scheme 17
In the course of a study on proline-like compounds with potential biological interest, Ponticelli and coworkers 53 have devised an approach toward the synthesis of functionalized spiro-pyrrolidine 63 (Scheme 18). In particular, treatment of pyrrolidine aldehyde 61 with the reducing reagent NaCNBH 3 , together with methylamine, gave rise to the β-amino ester 62. Subsequently, the cyclization of compound 62 using two equivalents of the strong base LDA led to the desired spiro-β-lactam 63. 53 In independent research, Sharada and coworkers have also described an effective synthesis of a pyrrolidine-derived spiro-β-lactam starting from natural proline. 54
Scheme 18
The Grainger group 55 has published the preparation of a spirocyclic β-lactam by using a 4-exo-trig carbamoyl radical cyclization approach. Specifically, amine 64, prepared in one step by reductive amination of commercially available 1-cyclohexene-1-carboxaldehyde with p-methoxyaniline, 11 was converted into the carbamoyl radical precursor 65 (Scheme 19) . Then, irradiation of compound 65 with a 500 W halogen lamp afforded spirocyclic dithiocarbamate 66 as a single diastereomer. The stereochemistry of compound 66 was determined by NOE spectral analysis, which showed the proton adjacent to sulfur to be on the same side of the cyclohexyl ring as the methylene group of the β-lactam. The reduction of 66 with H 3 PO 2 -ACCN successfully gave spirocyclic β-lactam 67. 55
Scheme 19
Spiro-β-lactam 75 has been synthesized as an intermediate compound in an effort to find drugs to improve hepatitis C virus (HCV) therapy (Scheme 20). 56 
Scheme 20
Indolenine β-lactams 77, present as key moieties in the complete structure of chartellines, were synthesized by an intramolecular nucleophilic substitution initiated by indolenine derivatives 76 using LiHMDS as a base (Scheme 21). 57
Scheme 21
A highly regioselective intramolecular amination of an sp 3 carbon in amide derivatives bearing an 8aminoquinolinyl group as the bidentate directing group using transition metal catalysts has recently attracted considerable attention of different research groups. [58] [59] [60] [61] [62] [63] The intramolecular dehydrogenative cyclization of aliphatic amides 78 afforded spiro-β-lactams 79 by utilizing a bidentate chelation and various oxidants in combination with copper, nickel and cobalt catalysts (Scheme 22). The formation of β-lactams was proposed to proceed in all cases via C-N bond-forming reductive elimination. 63
Scheme 22
The direct C-H cyclization of amides 80 bearing five-, six-and seven-membered rings proceeded via in situ iodonium ylide formation 80" without the assistance of a transition metal, delivering the corresponding spiroβ-lactams 81 in a single step (Scheme 23). From a mechanistic point of view, this transformation is consistent with the facile formation of a reactive singlet carbene. However, it circumvents the classical use of diazo substrates for C-H insertion chemistry. 64 In addition, this group has disclosed a diastereoselective synthesis of spirocyclic β-lactam derivative (-)-92 starting from optically pure azetidine-2,3-dione (+)-91 applying Passerini reaction conditions with bromoacetic acid and benzyl isocyanide, followed by the addition of the non-nucleophilic base N,N'-diisopropylethylamine (DIPEA) (Scheme 28). 73
Scheme 28
6-Diazopenicillanates 94 have been obtained in high yields by the combination of 6-β-aminopenicillanates 93 with ethyl nitrite at room temperature. Then, these 6-diazopenicillanates 94 were subjected to stereoselective 1,3-dipolar cycloaddition with acrylonitrile, acrylates and methyl vinyl ketone, giving the corresponding spiro-2-pyrazoline-β-lactam derivatives 95, 96 and 97 as major products (Scheme 29). It should be noted that the 1,3-dipolar cycloaddition was stereoselective, the major cycloadduct being the result of the dipolarophile addition to the less sterically hindered α-side of the β-lactam. 74
Scheme 29
In analogy, chiral spiropyrazolinepenicillanates 101, 102 and 103 were obtained in a stereoselective fashion via 1,3-dipolar cycloaddition of 6-alkylidenepenicillanates 100, prepared through Wittig reaction of the appropriate benzhydryl 6-oxopenicillanate 98 and phosphorus ylides 99, with the corresponding diphenyldiazomethane, diazomethane and phenyldiazomethane (Scheme 30). 75
Scheme 30
In another study, the use of 10 mol% copper(II) acetate monohydrate as a catalyst and air as the stoichiometric re-oxidant enabled the synthesis of spirocyclic oxindole β-lactam 105 via the cyclization of precursor 104 using mesitylene as the solvent (Scheme 31). 12, [76] [77] [78] 
Scheme 31
Halocyclization of seleno-or thio-substituted β-lactams containing a carbon-carbon multiple bond concerns one of the pioneering methods for synthesis of halogenated 4-pyrazolyl spirocyclic-β-lactams. [79] [80] [81] Bhalla has recently reported on the synthesis of halogenated 4-pyrazolyl spirocyclic-β-lactams 107-110 via halogen-mediated intrasulfenyl cyclization of cis-3-propynyloxy-4-pyrazolyl-β-lactams 106 (Scheme 32). The effect of halogenating reagents and selectivity on the formation of the product has been carefully considered. These novel spiro-β-lactams 107-110 have been submitted for molecular docking studies and in vitro evaluation for biological activity. 80
Scheme 32
The optically active α-methylene-β-lactam (S)-111 has been subjected to cyclopropanation with CH 2 N 2 in CH 2 Cl 2 and [3+2]-cycloaddition with diphenylnitrone, giving rise to the corresponding cyclopropane derivative (S)-112 in 85% yield and spiroisoxazolidine adduct (3S, 4S, 7S)-113 in 92% yield, respectively (Scheme 33). 82
Scheme 33
Recently, the deployment of 3-methylene-4-(trifluoromethyl)azetidin-2-ones 112 as versatile building blocks allowed access to novel spiro-fused β-lactam systems. In particular, 1,3-dipolar nitrone-olefin cycloaddition of 3-methylene-β-lactams 112 with either N-phenyl-or N-tert-butyl-α-phenylnitrone gave 3trifluoromethyl-5-oxa-2,6-diazaspiro [3.4] octan-1-ones 113 (Scheme 34). In addition, CF 3 -substituted spirocycles 115 and 116 were prepared upon treatment of the corresponding diols 114, derived from the OsO 4 -mediated oxidation of 3-methylene-β-lactams 112, with pTsOH in 2,2-dimethoxypropane and with triphosgene, respectively (Scheme 34). 83, 84 Furthermore, spiro-β-lactam 150 has been subjected to enolization using KHMDS in THF, and subsequent treatment of the enolate with Davis oxaziridine 151 or isoamyl nitrite led to the corresponding α-hydroxy lactam 152 or oxime 155 in high yields, respectively (Scheme 46). Then, the β-lactams 152 and 155 were successfully reduced using monochloroalane to give spirocyclic azetidines 153 and 156, respectively. The azetidin-3-ol 153 was further converted to the corresponding ketone 154 under Swern oxidation conditions. 100
Scheme 46
Bioactive Spiro-fused β-lactams
Spiro-β-lactams constitute an interesting class of bioactive compounds possessing a wide spectrum of activities, such as antibacterial, antiviral and antimicrobial effects. In addition, the use of spiro-β-lactams as βlactamase and cholesterol absorption inhibitors or synthetic intermediates for β-turn mimics and β-turn nucleators, has been documented. [11] [12] [13] 74, 101 In this section, a brief selection of renewed pharmacological applications of spiro-β-lactam systems will be considered. The new spiro-β-lactams 2 and dispiro-β-lactams 3 have been demonstrated to exhibit good to excellent antimalarial activities against chloroquine-resistant Plasmodium falciparum K14 strain with IC 50 varying from 5 to 32.2 mM. 14 The spirocyclic β-lactam 157 (Figure 2 ), supported on superparamagnetic Fe 3 O 4 @SiO 2 nanoparticles, enhanced the antibacterial activity in comparison with the corresponding spirocyclic β-lactam, which was supposed to be due to the synergic effect of the Fe 3 O 4 @SiO 2 /β-lactam combination. 102, 103 A number of novel spiro[azetidine-2,3 ' -indole]-2 ' ,4(1 ' H)-dione derivatives have been tested for anti-breast cancer activity, however, only 3-chloro-1-(o-tolyl)spiro[azetidine-2,3'-indoline]-2',4-dione 158 (Figure 2 ) displayed a significant cytotoxicity (IC 50 = 22.75-25.18 μM) for breast cancer cell lines after 48 h, which is comparable to the standard control drug doxorubicin. 104 Recently, ((2S,3R)-3-hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro [3.4] octan-2-yl)butanamide) 159 ( Figure 2 ) has been examined for in vitro and in vivo pharmalogical properties. This compound appeared to be a novel N-methyl-D-aspartate (NMDA) receptor-specific modulator that facilitates synaptic plasticity and has therapeutic potential for a variety of NMDA receptor-mediated central nervous system (CNS) disorders. 105, 106 
Conclusions
In conclusion, the potential pharmacological activities, along with significant synthetic applications of spirocyclic β-lactams, have given a fresh impetus to synthetic chemists to design novel spiro-β-lactam structures. Synthetic approaches toward spirocyclic β-lactams, including the Staudinger ketene-imine cyclocondensation, the cyclization of β-amino acids and β-functionalised amides and transformation reactions, have been improved in recent years (e.g., increase yield and stereoselectivity of reactions as well as the use of greener reaction conditions) and have been intensively discussed in this review. In view of their interesting chemical and biological properties, spirocyclic β-lactams are expected to attract considerable attention in the future as well.
